Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Mycoplasma-Induced Stevens-Johnson Syndrome
0.300 Biomarker disease CTD_human Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing. 25099164 2014
Mycoplasma-Induced Stevens-Johnson Syndrome
0.300 Biomarker disease CTD_human Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. 21428768 2011
Mycoplasma-Induced Stevens-Johnson Syndrome
0.300 Biomarker disease CTD_human Genetic and ethnic risk factors associated with drug hypersensitivity. 20485159 2010
Mycoplasma-Induced Stevens-Johnson Syndrome
0.300 Biomarker disease CTD_human HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions. 19694795 2010
Mycoplasma-Induced Stevens-Johnson Syndrome
0.300 Biomarker disease CTD_human Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. 20235791 2010
Mycoplasma-Induced Stevens-Johnson Syndrome
0.300 Biomarker disease CTD_human Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. 19915237 2010
Mycoplasma-Induced Stevens-Johnson Syndrome
0.300 Biomarker disease CTD_human Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. 18855540 2008
Mycoplasma-Induced Stevens-Johnson Syndrome
0.300 Biomarker disease CTD_human Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. 16538176 2006
Mycoplasma-Induced Stevens-Johnson Syndrome
0.300 Biomarker disease CTD_human Medical genetics: a marker for Stevens-Johnson syndrome. 15057820 2004